CJC-1295 & GHRP-6 Blend (10mg)

$86.00

CJC-1295 & GHRP-6 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines CJC-1295, a 29-residue GHRH analogue, with GHRP-6, a 6-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1101

  • Product: CJC-1295 & GHRP-6 Blend

  • Listed quantity: 10 mg

  • Components: CJC-1295 and GHRP-6

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: CJC-1295-GHRP-6-Blend-10mg Category:
Description

CJC-1295 & GHRP-6 Blend (10mg) for Laboratory Research

CJC-1295 & GHRP-6 Blend (10mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines CJC-1295, a synthetic 29-residue GHRH analogue, with GHRP-6, a synthetic 6-residue ghrelin mimetic. 1101

For laboratories looking to buy CJC-1295 & GHRP-6 Blend, this listing identifies a 10 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Blend Product Information

Property Listing information
Product name CJC-1295 & GHRP-6 Blend
Listed quantity 10 mg
Components CJC-1295 and GHRP-6
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.

Reference Molecular Characteristics

The following characteristics describe the reference structures of the two components. They are not analytical confirmation of an individual commercial blend batch.

Component Reference molecular formula Approximate molecular weight PubChem identifier
CJC-1295 C₁₅₂H₂₅₂N₄₄O₄₂ 3367.9 g/mol 91976842
GHRP-6 C₄₆H₅₆N₁₂O₆ 873.0 g/mol 4345065

The molecular formulas and molecular weights are documented in the CJC-1295 research summary and the GHRP-6 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1101

CJC-1295 Reference Sequence

The CJC-1295 reference sequence is:

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

CJC-1295 is also known as Mod GRF 1-29. It is a 29-amino-acid synthetic GHRH analogue. The sequence is documented in the CJC-1295 research summary and in the CJC-1295 research summary. 1106

GHRP-6 Reference Sequence

The GHRP-6 reference sequence is:

His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

GHRP-6 is also known as Growth Hormone Releasing Peptide-6. It is a synthetic 6-residue ghrelin mimetic with growth hormone-releasing activity. The sequence is documented in the GHRP-6 research summary and in the GHRP-6 research summary. 1101

GHRH and GHS-R1a Receptor Research

CJC-1295 binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1105

GHRP-6 is a selective growth hormone secretagogue receptor agonist that activates the GHS-R1a receptor. Receptor engagement activates phospholipase C, increasing intracellular calcium concentrations. 1101

A review of synthetic growth hormone-releasing peptides describes GHRP-6 as a small molecular weight peptide that binds the GHS-R1a, which activates protein kinase C signaling cascade. The same review notes that GHRP-6 rescued ischemic myocardium from ischemia/reperfusion injury. 1102

Growth Hormone Pulsatility Research

A study evaluating a CJC-1295 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. The same study reported an approximately 28% increase in IGF-1 levels. 1105

A separate study of GHRP-6 reported that the peptide may enhance the peak synthesis of growth hormone by pituitary cells by more than 60-fold. The investigators reported that GHRP-6 may elevate growth hormone levels during a peak to around 80 mIU/L, equivalent to about 26.6 ng/mL. 1101

These findings apply to specific experimental protocols and do not establish that a commercial blend increases growth hormone in humans. 1101

Research Limitations

Published CJC-1295 and GHRP-6 research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports recovery, or treats any condition. 1101

Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.

Documentation and Batch Verification

Before selecting CJC-1295 & GHRP-6 Blend (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component ratio and total blend quantity.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.

For inquiries, provide “CJC-1295 & GHRP-6 Blend (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About CJC-1295 & GHRP-6 Blend (10mg)

What is CJC-1295 & GHRP-6 Blend?

It is a research blend combining CJC-1295, a synthetic 29-residue GHRH analogue, with GHRP-6, a synthetic 6-residue ghrelin mimetic. 1101

What does the 10mg designation mean?

It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.

Does this blend increase growth hormone?

Published research examines receptor signaling and growth hormone release in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans. 1101

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

CJC-1295 & GHRP-6 Blend (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery